| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway
|
Guo, Songbin
|
|
|
85 |
6 |
p. 1097-1108
|
artikel
|
| 2 |
Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug
|
Juarez, Mandy
|
|
|
85 |
6 |
p. 1153-1163
|
artikel
|
| 3 |
A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors
|
Murray Stewart, Tracy
|
|
|
85 |
6 |
p. 1089-1096
|
artikel
|
| 4 |
Assessing the translational value of pre-clinical studies for clinical response rate in oncology: an exploratory investigation of 42 FDA-approved small-molecule targeted anticancer drugs
|
Liu, Wenying Angela
|
|
|
85 |
6 |
p. 1015-1027
|
artikel
|
| 5 |
CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model
|
Azambuja, J. H.
|
|
|
85 |
6 |
p. 1177-1182
|
artikel
|
| 6 |
Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
|
Fujimoto, Yoshiaki
|
|
|
85 |
6 |
p. 1029-1038
|
artikel
|
| 7 |
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer
|
Arora, Mansi
|
|
|
85 |
6 |
p. 1063-1078
|
artikel
|
| 8 |
Exposure–response analysis of endoxifen serum concentrations in early-breast cancer
|
Sanchez-Spitman, Anabel Beatriz
|
|
|
85 |
6 |
p. 1141-1152
|
artikel
|
| 9 |
Expression of Concern: shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells
|
Yang, Hongjian
|
|
|
85 |
6 |
p. 1183
|
artikel
|
| 10 |
In vitro drug sensitivity (IDS) of patient-derived primary osteosarcoma cells as an early predictor of the clinical outcomes of osteosarcoma patients
|
Klangjorhor, Jeerawan
|
|
|
85 |
6 |
p. 1165-1176
|
artikel
|
| 11 |
In vivo assessment of the drug interaction between sorafenib and paracetamol in rats
|
Karbownik, Agnieszka
|
|
|
85 |
6 |
p. 1039-1048
|
artikel
|
| 12 |
MEK inhibition overcomes everolimus resistance in gastric cancer
|
Liu, Hongfang
|
|
|
85 |
6 |
p. 1079-1087
|
artikel
|
| 13 |
NUC-1031 in biliary tract cancer: from bench to bedside and back?
|
Boyd, Lenka N. C.
|
|
|
85 |
6 |
p. 1011-1014
|
artikel
|
| 14 |
Pharmacokinetics and tolerability of fedratinib, an oral, selective Janus kinase 2 inhibitor, in subjects with renal or hepatic impairment
|
Ogasawara, Ken
|
|
|
85 |
6 |
p. 1109-1117
|
artikel
|
| 15 |
Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents
|
He, Guangan
|
|
|
85 |
6 |
p. 1129-1140
|
artikel
|
| 16 |
The gut microbiota attenuates muscle wasting by regulating energy metabolism in chemotherapy-induced malnutrition rats
|
Chen, Haitao
|
|
|
85 |
6 |
p. 1049-1062
|
artikel
|
| 17 |
Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients
|
Matsumoto, Natsumi
|
|
|
85 |
6 |
p. 1119-1128
|
artikel
|
Tijdschrift beschrijving